A Mutation of PCDH15 among Ashkenazi Jews with the Type 1 Usher Syndrome
Tamar Ben-Yosef, Ph.D., Seth L. Ness, M.D., Ph.D., Anne C. Madeo, M.S., Adi Bar-Lev, M.S., Jessica H. Wolfman, Zubair M. Ahmed, Ph.D., Robert J. Desnick, M.D., Ph.D., Judith P. Willner, M.D., Karen B. Avraham, Ph.D., Harry Ostrer, M.D., Carole Oddoux, Ph.D., Andrew J. Griffith, M.D., Ph.D., and Thomas B. Friedman, Ph.D.
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
The Usher syndrome is an autosomal recessive disorder characterizedby bilateral sensorineural deafness and progressive loss ofvision due to retinitis pigmentosa. It is the most frequentcause of deafness and concurrent blindness,1 with a prevalenceof 1 in 16,000 to 1 in 50,000.2 The majority of cases of theUsher syndrome can be classified into one of three clinicalsubtypes, the most severe of which is the type 1 Usher syndrome,characterized by profound prelingual hearing loss, vestibularareflexia, and prepubertal onset of retinitis pigmentosa.2 Sevenloci for the type 1 Usher syndrome (USH1A to USH1G) have . . . [Full Text of this Article]
Methods
Subjects
Detection of Mutations
Results
Discussion
Source Information
From the Laboratory of Molecular Genetics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, Md. (T.B.-Y., A.C.M., J.H.W., Z.M.A., A.J.G., T.B.F.); the Department of Human Genetics, Mount Sinai School of Medicine, New York (S.L.N., A.B.-L., R.J.D., J.P.W.); the Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (K.B.A.); and the Human Genetics Program, New York University School of Medicine, New York (H.O., C.O.).
Address reprint requests to Dr. Friedman at the Laboratory of Molecular Genetics, NIDCD, 5 Research Ct., Rm. 2A15, Rockville, MD 20850, or at friedman@nidcd.nih.gov.
This article has been cited by other articles:
Kaiserman, N., Obolensky, A., Banin, E., Sharon, D.
(2007). Novel USH2A Mutations in Israeli Patients With Retinitis Pigmentosa and Usher Syndrome Type 2. Arch Ophthalmol
125: 219-224
[Abstract][Full Text]
Roux, A-F, Faugere, V, Le Guedard, S, Pallares-Ruiz, N, Vielle, A, Chambert, S, Marlin, S, Hamel, C, Gilbert, B, Malcolm, S, Claustres, M, for the French Usher Syndrome Collaboration,
(2006). Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%. J. Med. Genet.
43: 763-768
[Abstract][Full Text]
Ahmed, Z. M., Goodyear, R., Riazuddin, S., Lagziel, A., Legan, P. K., Behra, M., Burgess, S. M., Lilley, K. S., Wilcox, E. R., Riazuddin, S., Griffith, A. J., Frolenkov, G. I., Belyantseva, I. A., Richardson, G. P., Friedman, T. B.
(2006). The tip-link antigen, a protein associated with the transduction complex of sensory hair cells, is protocadherin-15.. J. Neurosci.
26: 7022-7034
[Abstract][Full Text]
Seiler, C., Finger-Baier, K. C., Rinner, O., Makhankov, Y. V., Schwarz, H., Neuhauss, S. C. F., Nicolson, T.
(2005). Duplicated genes with split functions: independent roles of protocadherin15 orthologues in zebrafish hearing and vision. Development
132: 615-623
[Abstract][Full Text]
Ahmed, Z. M., Riazuddin, S., Ahmad, J., Bernstein, S. L., Guo, Y., Sabar, M. F., Sieving, P., Riazuddin, S., Griffith, A. J., Friedman, T. B., Belyantseva, I. A., Wilcox, E. R.
(2003). PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet
12: 3215-3223
[Abstract][Full Text]
Ness, S L, Ben-Yosef, T, Bar-Lev, A, Madeo, A C, Brewer, C C, Avraham, K B, Kornreich, R, Desnick, R J, Willner, J P, Friedman, T B, Griffith, A J
(2003). Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J. Med. Genet.
40: 767-772
[Full Text]